Sector ratings MBX Biosciences, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 21/07/2026 +04			5-day change	1st Jan Change
60.14 ^USD	-4.42%		+0.17%	+90.68%

07-14	MBX Biosciences Appoints Steve Hoerter as CEO; Kent Hawryluk Steps Down	MT
07-14	MBX Biosciences, Inc. Announces CEO Changes, Effective July 13, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation
MBX BIOSCIENCES, INC.	2.86B	-	BBB	-	-	-
LONZA GROUP AG	48.71B		AAA
REVOLUTION MEDICINES, INC.	38.35B	-	B	-		-
BEONE MEDICINES AG	34.53B		-
IQVIA HOLDINGS INC.	34.03B		AAA
CELLTRION, INC.	26.77B		A
ASCENDIS PHARMA A/S	15.64B	-	-	-		-
MEDPACE HOLDINGS, INC.	15.08B		BBB
EUROFINS SCIENTIFIC SE	14.18B		AA
ICON PUBLIC LIMITED COMPANY	12.73B		AAA
ABIVAX	11.61B	-	BBB	-		-
BIO-TECHNE CORPORATION	11.16B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.58B		AA
APOGEE THERAPEUTICS, INC.	10.05B	-	B	-		-
KYMERA THERAPEUTICS, INC.	9.14B	-	BBB	-		-
TEMPUS AI, INC.	8.69B		A			-
PROTAGONIST THERAPEUTICS, INC.	8.64B		BB			-
IONIS PHARMACEUTICALS, INC.	8.75B	-	A	-		-
PHARMARON BEIJING CO., LTD.	9.21B		AA
ALKERMES PLC	8.62B		A
Average	16.97B		A
Weighted average by Cap.			A